Lenalidomide not recommended as maintenance treatment for newly diagnosed multiple myeloma Regulatory alerts NICE guidance Regulatory Alerts, Cancer, Oncology, Haematological malignancies, Oncology Room Lenalidomide not recommended as maintenance treatment for newly diagnosed multiple myeloma OnMedica Sep 08, 2020
SMC accepts four oncology treatments Regulatory alerts Regulatory Alerts, Cancer, Oncology, Breast cancer, Genitourinary cancers, Haematological malignancies, Head and neck cancer, Oncology Room SMC accepts four oncology treatments OnMedica Sep 07, 2020
Regulatory alerts NICE guidance Regulatory Alerts, Cancer, Oncology, Haematological malignancies, Oncology Room Brentuximab vedotin in combination recommended for untreated systemic anaplastic large cell lymphoma OnMedica Aug 12, 2020
Regulatory alerts NICE guidance Regulatory Alerts, Cancer, Oncology, Haematological malignancies, Oncology Room Gilteritinib recommended for relapsed or refractory acute myeloid leukaemia OnMedica Aug 12, 2020
Regulatory alerts NICE guidance Regulatory Alerts, Cancer, Oncology, Haematological malignancies, Oncology Room Treosulfan with fludarabine recommended for malignant disease before allogeneic stem cell transplant OnMedica Aug 05, 2020
NICE does not recommend chlormethine gel for type of lymphoma Regulatory alerts NICE guidance Regulatory Alerts, Cancer, Oncology, Haematological malignancies, Oncology Room NICE does not recommend chlormethine gel for type of lymphoma OnMedica Aug 05, 2020
Gilteritinib recommended for relapsed or refractory acute myeloid leukaemia Regulatory alerts NICE guidance Regulatory Alerts, Cancer, Oncology, Haematological malignancies, Oncology Room Gilteritinib recommended for relapsed or refractory acute myeloid leukaemia OnMedica Jul 16, 2020
Haematology – Journal Spy Journal Spy, Haematology, Haematological malignancies Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility. ClinOwl Jul 10, 2020
Haematology – Journal Spy Journal Spy, Haematology, Haematological malignancies Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity. ClinOwl Jul 03, 2020
Haematology – Journal Spy Journal Spy, Haematology, Oncology, Haematological malignancies Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58. ClinOwl Jun 26, 2020
Isatuximab in combination not recommended for multiple myeloma Regulatory alerts NICE guidance Regulatory Alerts, Oncology, Haematological malignancies, Oncology Room Isatuximab in combination not recommended for multiple myeloma OnMedica Jun 04, 2020
Haematology – Journal Spy Journal Spy, Cancer, Haematology, Oncology, Haematological malignancies Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. ClinOwl May 29, 2020
Haematology – Journal Spy Journal Spy, Haematology, Oncology, Haematological malignancies Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome. ClinOwl May 22, 2020
Haematology – Journal Spy Journal Spy, Cancer, Haematology, Oncology, Haematological malignancies Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas. ClinOwl May 16, 2020
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients Oncology – Journal Spy Haematology, Oncology, Haematological malignancies Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients OnMedica Feb 06, 2020
Pattern of hospital visits offers clue to spotting people at risk of myeloma NCRI Cancer Conference News, Cancer, Oncology, Haematological malignancies Pattern of hospital visits offers clue to spotting people at risk of myeloma OnMedica Nov 04, 2019
